Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 5Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Motor Activity 2Gastrointestinal Neoplasms 2Vitamin D Deficiency 1Stomach Neoplasms 1Rectal Neoplasms 1Psychological Well-Being 1Prostatic Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Osteoporosis 1Neoplasms 1Myocardial Ischemia 1Lung Neoplasms 1Inflammation 1Hypertension 1Heart Diseases 1Fibrosis 1Esophageal Neoplasms 1Coronary Disease 1Cognitive Dysfunction 1Cholangiocarcinoma 1Cardiovascular Diseases 1Breast Neoplasms 1Bone Diseases 1

Interventions

beta Carotene 1Vitamin E 1Vitamin D 1Population Groups 1Neuropsychological Tests 1Geritol 1Ascorbic Acid 1Anesthesia, General 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Vitamin D × Gastrointestinal × Clear all
NCT05552729 2022-09-23

Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors

Yangzhou University

Phase 1/2 Unknown
114 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡